OCI GLOBAL CONFIRMS EURO EQUIVALENT DETAILS FOR Q2 2025 EXTRAORDINARY DISTRIBUTION

2025-04-17 OCI Global HaiPress

AMSTERDAM,April 16,2025 -- OCI Global (Euronext: OCI) ("OCI" or the "Company") today confirms that further to its announcement to pay an extraordinary cash distribution of USD 4.74 per share (USD 1.0 billion in total) on or around 7 May 2025,the Euro equivalent amount for those shareholders that elect for payment in EUR instead of USD will be determined using the appropriate exchange rate on 6 May 2025. The Company will make a distribution in USD unless the relevant shareholder has opted for a distribution in EUR.

AboutOCI Global

Learn more about OCI at www.oci-global.com. You can also follow OCI on LinkedIn.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Links

Handheld Inkjet Printer Australian Morning Post American fortune daily American People Network United States Newsletter BBC Network News American news network Startup Weekly New York City Morning Post Bloomberg Digital Journal Yahoo See industrial inkjet printer